Gynecologic Clinical Trials
Narrow List by Age:
(Refer to Clinical Summary for age requirements)
Gynecologic
| Protocol | NRG GY009 |
|---|---|
| Cancer Type: | Platinum Resistant Ovarian Cancer |
| Fast Facts |
A Randomized, Phase II/III Study of Pegylated Lipsomal Doxorubicin and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab versus Pegylated Liposomal Doxorubicin/Bevacizumab in Platinum Resistant Ovarian Cancer
| Protocol | NRG CC008 |
|---|---|
| Cancer Type: | Ovarian Cancer Among BRCA1 Carriers |
| Fast Facts |
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
| Protocol | NRG GY019 |
|---|---|
| Cancer Type: | Carcinoma of the Ovary or Peritoneum |
| Fast Facts |
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | GOG 0263 |
|---|---|
| Cancer Type: | Stage I/IIA Cervical Cancer |
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
| Protocol | NRG GY006 |
|---|---|
| Cancer Type: | GYN-newly diagnosed, bulky stage |
| Fast Facts |
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
| Protocol | RTOG 0724 |
|---|---|
| Cancer Type: | Cervical Carcinoma |
Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy With or Without Adjuvant Chemotherapy in High-Risk Patients With Early-Stage Cervical Carcinoma Following Radical Hysterectomy
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | NRG GY018 |
|---|---|
| Cancer Type: | ENDOMETRIAL CANCER |
| Fast Facts |
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | ACCRU 2018-01 |
|---|---|
| Cancer Type: | Untreated Solid Tumors |
| Fast Facts |
Blood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid Tumors
Please check out the rare protocol list to locate other studies within this disease site.
| Protocol | SWOG S1714 |
|---|---|
| Cancer Type: | Multiple Cancer control |
| Fast Facts |
A Prospective Observational Cohort Study to Develop A Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.
